The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers

Inflammation

Volumn 24, Issue 1, 2000, Pages 73-87

  Fernvik, Eva ^a   Lundahl, Joachim ^a   Halldén, Gunilla ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD9 ANTIGEN; EOTAXIN; FIBRONECTIN; INTEGRIN; INTERLEUKIN 5;

ADULT; ALLERGY; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL MIGRATION; DEGRANULATION; EOSINOPHILIA; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BIOLOGICAL MARKERS; BLOOD PROTEINS; CELL ADHESION; CELL MOVEMENT; CHEMOKINES, CC; CYTOKINES; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; EPITOPES; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERLEUKIN-5; INTRACELLULAR MEMBRANES; MACROPHAGE-1 ANTIGEN; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, LYMPHOCYTE HOMING; RIBONUCLEASES;

EID: 0033982186     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006940109869     Document Type: Article

References (46)

1. GLEICH, G.J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422-36.
2. BOUSQUET, J., P. CHANEZ, J. Y. LACOSTE, G. BARNEON, N. GHEVANIAN, I. ENANDER, P. VENGE, S. AHLSTEDT, J. SIMONY-LAFONTAINE, P. GODARD, and F. MICHEL. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
3. KAY, A. B. 1991. Asthma and inflammation. J. Allergy Clin. Immunol. 87:893-910.
4. HOLGATE, S. T., W. R. ROCHE, and M. K. CHURCH. 1991. The role of eosinophils in asthma. Am. Rev. Respir. Dis. 143:S66-S70.
5. GLEICH, G. J., H. KITA, and C. R. ADOLPHSON. 1994. Eosinophils. In: Samter's Immunological Diseases, 5th. Frank, S. M., K. F. Austen, H. N. Claman, and E. R. Unanue, editors. pp. 205-245. Little, Brown and Company, Boston, MA.
6. WELLER, P., T. RAND, S. GOELZ, G. CHI-ROSSO, and R. LOBB. 1991. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule-1 and endothelial leukocyte adhesion molecule-1. Proc. Natl. Acad. Sci. U.S.A. 88:7430-7434.
7. SPRINGER, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314.
8. CARLOS, T. M., and J. M. HARLAN. 1994. Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101.
9. KANSAS, G. S. 1996. Selectins and their ligands: Current concepts and controversies. Blood 88:3259-3287.
10. 1 (very late antigen-4) dependent. J. Immunol. 146:3419-3423.
11. DOBRINA, A., R. MENEGAZZI, T. M. CARLOS, E. NARDON, R. CRAMER, T. ZACCHI, J. M. HARLAN, and P. PATRIARCA. 1991. Mechanisms of eosinophil adherence to cultured vascular endothelial cells: eosinophils bind to cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J. Clin. Invest. 88:20-26.
12. SRIRAMARAO, P., U. H. VON ANDRIAN, E. C. BUTCHER, M. A. BOURDON, and D. H. BROIDE. 1994. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J. Immunol. 153:4238-4246.
13. 4-integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo. J. Exp. Med. 183:1995-2006.
14. WEG, V. B., T. J. WILLIAMS, R. R. LOBB, and S. NOURSHARGH. 1993. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J. Exp. Med. 177:561-566.
15. WALKER, C., S. RIHS, R. BRAUN, S. BETZ, and P. BRUIJNZEEL. 1993. Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J. Immunol. 150:4061-4071.
16. STANISLAWSKI, L., T. P. HUU, and A. PERIANIN. 1990. Priming effect of fibronectin on respiratory burst of human neutrophils induced by formyl peptides and platelet-activating factor. Inflammation 14:523-530.
17. ISSEKUTZ, T. B. 1995. In vivo blood monocyte to acute inflammatory reactions, IL-1 alpha, TNF-alpha, IFN-gamma, and C5a utilizes LFA-1, Mac-1 and VLA-4. The relative importance of each integrin. J. Immunol. 154:6533-6540.
18. WALSH, G. M., F. A. SYMON, and A. J. WARDLAW. 1995. Human eosinophils preferentially survive on tissue fibronectin compared to plasma fibronectin. Clin. Exp. Allergy 25:1128-1136.
19. ÄDELROTH, E., L. ROSENHALL, S.-A . JOHANSSON, M. LINDEN, and P. VENGE. 1990. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. Am. Rev. Respir. Dis. 142:91-99.
20. VENGE, P. 1993. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin. Exp. Allergy 23:3-7.
21. HALLDÉN, G., and J. HED. 1993. The FOG-method-A new approach to detecting activated eosinophils, ACI News 5:139-143.
22. JAHNSEN, F. L., P. BRANDTZAEG, and T. S. HALSTENSEN. 1994. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. J. Immunol. Methods 175:23-36.
23. SKEDINGER, M., G. HALLDÉN, J. LUNDAHL, J. HED, and O. ZETTERSTRÖM. 1995. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course. Ann. Allergy, Asthma & Immunol. 74:250-255.
24. FERNVIK, E., R. GRÖNNEBERG, J. LUNDAHL, J. HED, O. ANDERSSON, S. G. O. JOHANSSON, and G. HALLDÉN. 1996. The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma. Allergy 51:697-705.
25. ARM, J. P., M. J. WALPORT, and T. H. LEE. 1989. Expression of complement receptors type 1 (CR1) and type 3 (CR3) on circulating granulocytes in experimentally provoked asthma. J. Allergy Clin. Immunol. 83:649-655.
26. LUNDAHL, J., A. MOSHFEGH, R. GRÖNNEBERG, and G. HALLDÉN. 1998. Eotaxin increases the expression of CD11b/CD18 and adhesion properties in IL-5 but not fMLP pre-stimulated human peripheral blood eosinophils. Inflammation 22:123-135.
27. FERNVIK, E., G. HALLDÉN, J. HED, and J. LUNDAHL. 1995. Intracellular and surface distribution of CD9 in human eosinophils. APMIS 103:699-706.
28. FERNVIK, E., J. LUNDAHL C. G. M. MAGNUSSON, and G. HALLDÉN. 1999. The effect of in vitro activation and platelet interaction on the CD9 distribution and adhesion properties of human eosinophils. Inflammation Research 48:28-35.
29. KIM, J. Y., G. GLEICH, and H. KITA. 1997. Roles of CD9 molecules in survival and activation and human eosinophils. J. Immunol. 159:926-933.
30. HANSEL, T., J. DE VRIES, T. IFF, S. RIHS, M. WANDZILAK, and S. BETZ. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145:105-110.
31. HED, J., O. BERG, J. FORSLID, G. HALLDÉN, and G. LÄRKA-RAFNER. 1988. The expression of CR1 and CR3 on non-modulated and modulated granulocytes of healthy blood donors as measured by flow cytofluorometry. Scand. J. Immunol. 28:339-344.
32. HED, J., and G. HALLDÉN. 1993. Counts of activated blood eosinophils for monitoring asthma. Allergy 48:87-93.
33. HALLDÉN, G., U. ANDERSSON, J. HED, and S. G. O. JOHANSSON. 1989. A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry. J. Immunol. Methods 124:103-109.
34. GONZALO, J. A., C. M. LLOYD, L. KREMER, E. FINGER, C. MARTINEZ-A, M. H. SIEGELMAN, M. CYBULSKY, and J.-C. GUTIERREZ-RAMOS. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation. J. Clin. Invest. 98:2332-2345.
35. TAI, P. C., L. SUN, and C. J. F. SPRY. 1991. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol. 85:312-316.
36. SEHMI, R., A. J. WARDLAW, O. CROMWELL, K. KURIHARA, P. WALTMANN, and A. B. KAY. 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilc subjects. Blood 79:2952-2959.
37. FERNVIK, E., R. GRÖNNEBERG, J. LUNDAHL, M. VAN HAGE-HAMSTEN, J. RAUD, O. ZETTERSTRÖM, and G. HALLDÉN, G. 1999. Characterisation of eosinophils and detection of eotaxin in skin chamber fluid after challenge with relevant allergen in patients with mild asthma. Clin. Exp. Allergy (In press).
38. KIMANI, G., M. G. TONNESEN, and P. M. HENSON. 1988. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J. Immunol. 140:3161-3166.
39. HARTNELL, A., R. MOQBEL, G. M. WALSH, D. BRADLEY, and A. B. KAY. 1990. Fcγ and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology 69:264-270.
40. THORNE, K. J. I., B. A. RICHARDSON, G. MAZZA, and A. E. BUTTERWORTH. 1990. A new method for measuring eosinophil activating factors based on the increased expression of CR3 α chain (CD11b) on the surface of activated eosinophils. J. Immunol. Methods 133:47-54.
41. O'SHEA, J., E. J. BROWN, B. E. SELIGMANN, J. A. METCALF, M. M. FRANK, and J. I. GALLIN. 1985. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:2580-2587.
42. LUNDAHL, J., G. HALLDÉN, and J. HED. 1993. Differences in intracellular pool and receptor-dependent mobilization of the adhesion-promoting glycoprotein Mac-1 between eosinophils and neutrophils. J. Leukoc. Biol. 53:336-341.
43. BOUCHEIX, C., C. SORIA, M. MIRSHAHI, J. SORIA, J.-Y. PERROT, N. FOURNIER, M. BILLARD, and N. ROSENFELD. 1983. Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p24): Inhibition of aggregation by ALB6Fab. FEBS Lett. 161:289-295.
44. RUBINSTEIN, E., F. L. NAOUR, M. BILLARD, M. PRENANT, and C. BOUCHEIX. 1994. CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur. J. Immunol. 24:3005-3013.
45. M-SMITH, A., G. S. JENSON, J. G. SEEHAFER, J. R. SLUPSKY, and A. R. E. SHAW. 1990. Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J. Immunol. 144:1607-1613.
46. GRIFFITH, L., J. SLUPSKY, J. SEEHAFER, L. BOSHOKOV, and A. R. E. SHAW. 1991. Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal. Blood 78:1753-1759.